Medicare Enrolled

Dr. David Kritz, MD

Family Medicine · Orange, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1140 W LA VETA AVE, Orange, CA 92868
7145475404
In practice since 2007 (19 years)
NPI: 1346376142 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kritz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kritz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kritz

Dr. David Kritz is a family medicine specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kritz performed 425 Medicare services across 282 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kritz received a total of $11,355 from 48 pharmaceutical and/or device companies across 492 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kritz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 48% volume in CA $11,355 industry payments

Medicare Practice Summary

Medicare Utilization ↗
425
Medicare services
Top 48% in CA for family medicine
282
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~22 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
234 $89 $241
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $56 $164
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
38 $33 $54
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
36 $72 $107
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
26 $140 $263
Pneumococcal vaccine, 23-valent
A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria.
14 $131 $215
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
14 $33 $54
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
11 $12 $70
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,355
Total received (2018-2024)
Avg $1,622/year across 7 years
Top 4% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
492
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,355 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,240
2023
$1,544
2022
$1,497
2021
$1,195
2020
$486
2019
$1,832
2018
$2,561

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$650
Phathom Pharmaceuticals, Inc.
$256
GlaxoSmithKline, LLC.
$231
Lilly USA, LLC
$230
Boehringer Ingelheim Pharmaceuticals, Inc.
$167
Novo Nordisk Inc
$141
Boston Scientific Corporation
$133
ABIOMED
$131
PFIZER INC.
$76
Bayer Healthcare Pharmaceuticals Inc.
$56
Abbott Laboratories
$51
Janssen Pharmaceuticals, Inc
$37
Exact Sciences Corporation
$22
ABBVIE INC.
$21
SANOFI-AVENTIS U.S. LLC
$21
Dexcom, Inc.
$17
Top 3 companies account for 50.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,197
GlaxoSmithKline, LLC.
$940
Novo Nordisk Inc
$871
Lilly USA, LLC
$794
Boehringer Ingelheim Pharmaceuticals, Inc.
$773
Merck Sharp & Dohme Corporation
$563
Janssen Pharmaceuticals, Inc
$545
PFIZER INC.
$460
ABIOMED
$439
Novartis Pharmaceuticals Corporation
$328
Boston Scientific Corporation
$320
Abbott Laboratories
$293
Amgen Inc.
$285
Astellas Pharma US Inc
$260
Phathom Pharmaceuticals, Inc.
$256
SANOFI-AVENTIS U.S. LLC
$231
Merck Sharp & Dohme LLC
$199
Bayer HealthCare Pharmaceuticals Inc.
$153
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$145
ABBVIE INC.
$139
BIOTRONIK INC.
$135
Amarin Pharma Inc.
$128
Teleflex LLC
$98
Teva Pharmaceuticals USA, Inc.
$94
Bayer Healthcare Pharmaceuticals Inc.
$75
AbbVie Inc.
$62
Exeltis, USA Inc.
$52
Exact Sciences Corporation
$44
E.R. Squibb & Sons, L.L.C.
$44
DEXCOM, INC.
$41
Grifols USA, LLC
$37
Daiichi Sankyo Inc.
$35
SANOFI PASTEUR INC.
$34
Dexcom, Inc.
$33
Sanofi Pasteur Inc.
$27
Averitas Pharma Inc.
$23
Sun Pharmaceutical Industries Inc.
$22
MAYNE PHARMA COMMERCIAL LLC
$22
ACADIA Pharmaceuticals Inc
$22
TerSera Therapeutics LLC
$18
Edwards Lifesciences Corporation
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
AbbVie, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$16
Circassia Pharmaceuticals Inc
$15
Eisai Inc.
$14
Seqirus USA Inc
$12
Medtronic MiniMed, Inc.
$11
Top 3 companies account for 35.3% of all-time payments
Associated products mentioned in payments ›
ADACEL · AIRSUPRA · AJOVY · ANORO · AREXVY · Aimovig · Androgel · Assurity Pacemaker · BELSOMRA · BREO · BREZTRI · BRILINTA · BYDUREON · CHANTIX · CRYSVITA · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EVUSHELD · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUMIST QUADRIVALENT · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre · GARDASIL 9 · GENERAL TACHY · INJECTAFER · INVEGA SUSTENNA · INVOKANA · Impella · JANUVIA · JARDIANCE · KAPSPARGO · Kerendia · LANTUS · LEQVIO · LifeVest · MENACTRA · MOUNJARO · MOVANTIK · MYRBETRIQ · NUCALA · NUPLAZID · NURTEC ODT · Ozempic · PNEUMOVAX 23 · PRADAXA · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PRIALT · Prolastin-C Liquid · Prolia · QULIPTA · QUTENZA · RELISTOR ORAL · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SLYND · SOLIQUA · SOLIQUA 100/33 · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TZIELD · UBRELVY · UROLIFT · VESICARE · VOQUEZNA · VRAYLAR · Vascepa · Victoza · WATCHMAN Access System · WATCHMAN FLX · XARELTO · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in CA.

Looking for a family medicine specialist in Orange?
Compare family medicine physicians in the Orange area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,921
Per 100K population
92.3
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kritz is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kritz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kritz performed 234 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kritz receive payments from pharmaceutical companies?
Yes. Dr. Kritz received a total of $11,355 from 48 companies across 492 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kritz's costs compare to other family medicine physicians in Orange?
Dr. Kritz's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kritz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →